AL
BIIB icon

Airain Ltd’s Biogen BIIB Stock Holding History

Airain Ltd’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$17.4M Buy
64,303
+16,546
+35% +$4.38M 0.77% 18
2017
Q1 		$13.1M Buy
47,757
+11,923
+33% +$3.37M 0.64% 41
2016
Q4 		$10.2M Buy
+35,834
New +$10.6M 0.82% 25
2016
Q3 		– Sell
-47,462
Closed -$11.5M – 624
2016
Q2 		$11.5M Buy
+47,462
New +$12.5M 0.66% 28
2015
Q4 		– Sell
-21,987
Closed -$6.42M – 838
2015
Q3 		$6.42M Sell
21,987
-2,066
-9% -$682K 0.38% 77
2015
Q2 		$9.72M Sell
24,053
-4,667
-16% -$1.87M 0.55% 40
2015
Q1 		$12.1M Buy
28,720
+2,696
+10% +$1.06M 0.74% 13
2014
Q4 		$8.83M Sell
26,024
-998
-4% -$323K 0.72% 26
2014
Q3 		$8.94M Buy
27,022
+23,262
+619% +$7.67M 0.61% 24
2014
Q2 		$1.19M Buy
+3,760
New +$1.13M 0.1% 227
2014
Q1 		– Sell
-8,003
Closed -$2.24M – 706
2013
Q4 		$2.24M Buy
8,003
+7,003
+700% +$1.81M 0.29% 97
2013
Q3 		$241K Buy
+1,000
New +$224K 0.04% 367

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Airain Ltd's BIIB Position: Q2 2017 in Review

Airain Ltd increased its Biogen (BIIB) stake by 35% in Q2 2017, buying an estimated $4.38M and bringing the position to 64,303 shares worth $17.4M. The position accounts for 0.77% of the portfolio, ranked #18.

Airain Ltd first reported a position in BIIB in Q3 2013 and has held it in 12 quarters since. 992 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

  • Airain Ltd held 64,303 shares of Biogen worth $17.4M as of Q2 2017.
  • Airain Ltd bought 16,546 Biogen shares in Q2 2017, an estimated $4.38M.
  • Biogen made up 0.77% of Airain Ltd's portfolio in Q2 2017, its #18 holding.
  • Airain Ltd first reported a position in Biogen in Q3 2013 and has held it in 12 quarters since.
  • 992 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.